Proactive news snapshot: Redx Pharma, Tissue Regenix, SDX Energy …
Chaarat Gold Holdings Ltd (LON:CGH) has unveiled a proposal to acquire the Kumtor mine, one of the largest gold mines in Central Asia, from Centerra Gold. It would be part of a three-way deal between Chaarat, Centerra and Kyrgyz state consortium, Kyrgyzaltyn OJSC.
Drug discovery group Redx Pharma Plc (LON:REDX) has pulled off a major coup with the appointment of a senior executive from drugs giant AstraZeneca PLC (LON:AZN) as its new chief executive. She is 49-year-old Lisa Anson, who has been AZ's UK president since 2012 and has worked for the company for more than two decades.
Growing medical devices group Tissue Regenix Group PLC (LON:TRX) said DermaPure products processed through the recently-acquired CellRight Technologies facility in San Antonio, Texas, are now on sale in the US. It follows the completion ahead of schedule of the manufacturing technical transfer.
SDX Energy Inc (LON:SDX, CVE:SDX) has announced another new discovery, in the Rabul 4 Well in Egypt's West Gharib concession. The well was drilled down to 5,250 feet and encountered 43 feet of net heavy oil pay, across the Yusr and Bakr formations. The company said the average porosity measured 16%.
OptiBiotix Health plc (LON:OPTI) has entered into a non-exclusive agreement for Cambridge Commodities Ltd (CCL) to distribute its SlimBiome weight management technology in the UK.
Specialist tech investor Sure Ventures PLC (LON:SURE) has made its first direct investment in the UK. The venture capital fund is putting £500,000 into Immotion Group, a Manchester-based group that specialises in virtual reality cinema pods.
Related news
- Yellow Diamonds - A Gap in the Diamond market
- Coffee with Samso: Episode 1, Australian Tungsten Projects and How the Chinese Market View The Tungsten sector
- Chasing for Kryptonite, the unknown other Lithium source
- What is In-Situ Recovery? Mining in a National Park with no environmental footprint
- Buds & Duds: Cannabis stocks drop but Weekend Unlimited shares jump on CBD hemp seed news
- Hemispherx treats first patient with cancer drug Ampligen in Phase 2 clinical trials
- THC Global granted cannabis Manufacture Licence, shares surge 20%
.jpg)